Evidence map›Paper›PMID 39737308›Full record

ArticleCureus2024

Peritoneal Dissemination and Malignant Ascites in Duodenal Cancer Successfully Treated With Adoptive Cell Therapy Using WT1- and MUC1-Pulsed Dendritic Cells and Activated T Cells With No Adverse Effects: A Case Report.

Yohsuke Yagawa, Yasunobu Kobayashi, Izumi Fujita, Manabu Watanabe, Shigeo Koido, Haruo Sugiyama, Keishi Tanigawa

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yohsuke YagawaDepartment of Immunotherapy, Bio-Thera Clinic, Tokyo, JPN.
Yasunobu KobayashiDepartment of Immunotherapy, Bio-Thera Clinic, Tokyo, JPN.
Izumi FujitaDepartment of Surgery, Ebara Hospital, Tokyo, JPN.
Manabu WatanabeDepartment of Surgery, Toho University Ohashi Medical Center, Tokyo, JPN.
Shigeo KoidoInternal Medicine, The Jikei University School of Medicine, Tokyo, JPN.
Haruo SugiyamaDepartment of Cancer Immunology, Osaka University Graduate School of Medcine, Osaka, JPN.
Keishi TanigawaDepartment of Immunotherapy, Bio-Thera Clinic, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A satisfactory treatment for the dissemination of duodenal cancer has not yet been established. We describe a case of peritoneal dissemination and malignant ascites in duodenal cancer that was successfully treated with adoptive cell therapy with no adverse effects. A 72-year-old Japanese male patient with primary duodenal cancer with distal lymph node metastases received chemotherapy with S-1, an oral pyrimidine fluoride

Indexed as

dendritic cellsduodenal cancermalignant ascitesmuc1peritoneal disseminationwt1

Identifiers

PMID39737308
PMCPMC11684412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.